Companies: 10,795·Total market cap: $144.5T
Agenus Inc.

Agenus Inc.

AGENNASDAQHealthcare● Active
$3.14
$-0.09(-2.79%)
Market Cap$130757136
P/E Ratio
52W High$7.34
52W Low$2.71

Agenus Inc. (AGEN) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

agen · stock forecast · 11 analysts (3M) · FMP · updated Jun 9, 2026

Analyst Rating & Consensus

Based on 11 Wall Street analysts in the past 3 months

SellBuy

Buy

11 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
8
Hold
3
Sell
0
Strong Sell
0
Total: 11 · Buy rate: 72.7%

12-Month Price Target

High

$8.00

Consensus

$7.33

+133.4% upside

Low

$7.00

Median: $7 · Last Close: $3.14

The Agenus Inc. (AGEN) analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month AGEN price target is $7.33, representing +133.4% upside from the current price of $3.14.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $7 (133.4%)

Consensus Target

$7.33

133.4% upside

High Target

$8

154.8%

Low Target

$7

122.9%

Current Price

$3.14

as of today

Based on analyst price targets, the AGEN stock price prediction for the next 12 months ranges from $7 to $8. The consensus AGEN price forecast of $7.33 implies 133.4% upside from the current price of $3.14.

Short-Term Price Prediction

Low Activity

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$3.110.89%

1-day model range: $3.04–$3.18. Peak: $3.18 (-0.89%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027-50.0%
2028-62.5%
2029-67.2%
2030-69.2%
2031-70.2%
Confidence:Very Low
⚠️ 2027 projections carry Very Low confidence. Treat as directional guidance only.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

🚫

Insufficient Trading Activity — Sentiment Signals Disabled

This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.

RSI (14)49.2
MACDBEARISH

Moving Averages · AGEN · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$3.27SELL
MA 10$3.35SELL
MA 20$3.32SELL
MA 50$3.72SELL
MA 100$3.48SELL
MA 200$3.78SELL
Current $AGEN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$3.26SELL
EMA 10$3.31SELL
EMA 20$3.40SELL
EMA 50$3.54SELL
EMA 100$3.61SELL
EMA 200$3.75SELL
Current $AGEN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2025-09-10
Maintains
BuyBuy
HC Wainwright & Co.2025-08-28
Maintains
BuyBuy
HC Wainwright & Co.2025-06-04
Upgrade ↑
NeutralBuy
Baird2025-06-04
Maintains
NeutralNeutral
Baird2025-05-13
Maintains
NeutralNeutral
HC Wainwright & Co.2025-05-13
Maintains
NeutralNeutral
HC Wainwright & Co.2025-04-30
Maintains
NeutralNeutral
HC Wainwright & Co.2025-03-18
Maintains
NeutralNeutral
HC Wainwright & Co.2025-03-12
Maintains
NeutralNeutral
Baird2025-03-12
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Agenus Inc. (AGEN) stock. Of the recent 48 rating actions, 2 were upgrades and 5 were downgrades. 11 analysts currently cover AGEN.

Analyst Recommendation Trends

Buy ratings01↑ +1
Hold ratings303
Sell ratings00

AGEN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$136M

↑ 6.6% YoY

Revenue Next Year

$138M

↑ 1.1% YoY

EPS This Year

$0.79

EPS Next Year

$-0.18

↓ 122.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AGEN EPS of $0.79 for the current fiscal year, based on estimates from 1 analysts. The AGEN revenue forecast is $136M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The AGEN stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AGEN price target is $7.33 (+133.4% upside), with an analyst consensus of Buy.

The AGEN short-term stock prediction for tomorrow is $3.11 (-0.89%). The AGEN stock prediction for 2030 projects a range of $1–$1.

Agenus Inc. trades on NASDAQ under the ticker AGEN. The AGEN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 73% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

AGEN forecast · 8 questions

According to 11 Wall Street analysts, the average 12-month AGEN price target is $7.33, with a high forecast of $8.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +133.4% potential upside from the current price of $3.14.

AGEN price targetWhat is AGEN price targetAGEN analyst price targetAGEN 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.